Login

Prof. Rob Phillips, CEO of Uscom 00:00:00

Share On Facebook Share On Twitter

Prof. Rob Phillips, CEO of Uscom

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Evergrande's Debt Crisis: A Ticking Domino for China's Economy
00:10:00
Reviving Yukon's Brewery Creek Gold Project: Insights from 121 Mining Investment Conference
00:10:00
James Clarke Reveals the Operators-First Philosophy Driving Clarke Capital Partners | James Clarke, Founder and CEO, Clarke Capital Partners
00:10:00
Martin Vohánka, CEO of Eurowag, on Leading the Transition to a Low-Carbon Digital Future in Road Transport | Martin Vohánka, CEO, W.A.G. Payment Solutions PLC.
00:10:00
Cardinal Energy Limited ASX:CE1 - A few words from Chairman, Glenn Whiddon | M. Scott Ratushny, CEO, Cardinal Energy Ltd (Alberta)CJ:TOR
00:10:00
Jos Sclater: SiA Programme's Impact on Business Growth |Jos Sclater - Chief Executive Officer of Avon Protection
00:10:00
Introduction to the Old Mutual Multi-Managers' Global Fund Range
00:10:00
Empowering Women at M&G Investments: An Interview with Valeria Locatelli and Her Team
00:10:00
8VC partners with elite founders to build transformational technologies|Alex Kolicich,Founding Partner,8VC
00:10:00
Revolutionizing Lithium: Net Zero Emissions and Renewable Energy in Germany | Vincent Ledoux Pendailles , Vice President, Vulcan Energy Resources Ltd.
00:10:00
Episode In the Beginning is presented by Goliath Resources | Roger Rosmus, Founder, CEO & Director, Goliath Resources Limited (CS)
00:10:00
working in the digital redesign of the everyday economy|David Beisel,Co-Founder and Partner,NextView Ventures

© 2026 Nehu